We estimate that the CEO of COHEN & STEERS, INC. ($CNS), Joseph Harvey, received a compensation of $6,991,951 in 2025. This is an increase of 19.32% from an estimated $5,641,074 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 20, 2026. Note that parsing errors may occur.
You can track $CNS on Quiver Quantitative's $CNS stock dashboard.
$CNS Stock Insider Trading Activity
$CNS Stock insiders have traded $CNS stock on the open market 27 times in the past 6 months. Of those trades, 24 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CNS stock by insiders over the last 6 months:
- ROBERT HAMILTON STEERS (Executive Chairman) has made 20 purchases buying 166,427 shares for an estimated $11,201,967 and 0 sales.
- MARTIN COHEN has made 4 purchases buying 100,000 shares for an estimated $5,982,411 and 0 sales.
- FRANCIS C POLI (GC, Secretary, EVP) has made 0 purchases and 3 sales selling 19,696 shares for an estimated $1,293,667.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNS Stock Congressional Stock Trading
Members of Congress have traded $CNS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CNS stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CNS Stock Hedge Fund Activity
We have seen 143 institutional investors add shares of $CNS Stock stock to their portfolio, and 170 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAMCO INC /NY/ removed 1,563,311 shares (-90.4%) from their portfolio in Q4 2025, for an estimated $98,144,664
- CONGRESS ASSET MANAGEMENT CO removed 638,651 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $40,094,509
- GOLDMAN SACHS GROUP INC added 526,096 shares (+215.6%) to their portfolio in Q4 2025, for an estimated $33,028,306
- CLEARBRIDGE INVESTMENTS, LLC removed 509,801 shares (-54.3%) from their portfolio in Q4 2025, for an estimated $32,005,306
- MORGAN STANLEY removed 485,017 shares (-54.1%) from their portfolio in Q4 2025, for an estimated $30,449,367
- MILLENNIUM MANAGEMENT LLC added 348,452 shares (+385.6%) to their portfolio in Q4 2025, for an estimated $21,875,816
- BOSTON TRUST WALDEN CORP removed 280,512 shares (-30.7%) from their portfolio in Q4 2025, for an estimated $17,610,543
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CNS Stock Analyst Ratings
Wall Street analysts have issued reports on $CNS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 10/09/2025
- B of A Securities issued a "Underperform" rating on 10/02/2025
To track analyst ratings and price targets for $CNS Stock, check out Quiver Quantitative's $CNS forecast page.
$CNS Stock Price Targets
Multiple analysts have issued price targets for $CNS recently. We have seen 2 analysts offer price targets for $CNS in the last 6 months, with a median target of $72.5.
Here are some recent targets:
- John Dunn from Evercore ISI Group set a target price of $77.0 on 10/20/2025
- Craig Siegenthaler from B of A Securities set a target price of $68.0 on 10/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
